Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 1;16(4):e0249344.
doi: 10.1371/journal.pone.0249344. eCollection 2021.

Effect of prolactin on normal and keratoconus human corneal stromal fibroblasts in vitro

Affiliations

Effect of prolactin on normal and keratoconus human corneal stromal fibroblasts in vitro

Philipp Anders et al. PLoS One. .

Abstract

Purpose: To examine the effect of prolactin (PRL) on human corneal stromal fibroblasts (CSFs), derived from healthy individuals and from keratoconus (KC) patients, in vitro, specifically assessing physiological and elevated PRL concentrations as apparent during pregnancy.

Methods: Eye bank corneas of 3 female and 3 male healthy individuals as well as the corneal buttons of 3 female and 3 male KC patients were utilized for this study. The endothelium of the cornea was removed with sterile surgical scalpels, the probes were washed repeatedly with Dulbecco's PBS and corneoscleral rims were trimmed off. Subsequently the corneal stroma was digested with collagenase type I and the harvested CSFs were cultured. We then examined (1) cell proliferation, (2) cell viability and (3) cytokine release of CSFs upon exposure to prolactin in vitro.

Results: With respect to viability and proliferation our experiments did not show significant differences between CSFs exposed to different PRL concentrations. Our data show a significantly lower IL-8 concentration in normal CSFs exposed to 10ng/ml PRL compared to 0ng/ml and 1000ng/ml at 5 hours post exposition. Moreover, we can report significantly lower secretion of IL-8, IL-6, HGF, VEGF and FGFb in KC CSFs compared to normal CSFs, independent of PRL exposure, as determined by cytokine ELISA.

Conclusion: Our data in part points towards corneal cytokine secretion as a possible link between altered stromal PRL concentrations and KC progression. However, in our small dataset a significant influence of PRL concentration on cytokine secretion can only be described for IL-8 in normal CSFs. Further our results contribute to existing reports on the importance of cytokines in KC development, with an emphasis on significantly lower cytokine secretion in KC CSFs compared to normal controls.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Viability of CSFs 24h after prolactin treatment.
(a) Pooled male and female normal CSFs (cells from 6 individual corneas were obtained and the assay was performed on 4 separate cell-wells per individual cornea, for which the values were averaged: n = 6; 4 technical replicates each) (b) Pooled male and female KC CSFs (n = 6; 4 technical replicates each). Data plotted as mean ± SD.
Fig 2
Fig 2. Cytokine secretion of CSFs 5h after prolactin treatment.
Pooled male and female CSFs for both normal and KC (cells from 6 individual corneas were obtained and the assay was performed on 4 separate cell-wells per individual cornea, for which the values were averaged: n = 6; 4 technical replicates each). The secretion of IL-6 in KC CSFs was below the detection limit. Data plotted as individual data points, mean ± SD. (* P ≤ 0.05).
Fig 3
Fig 3. Cytokine secretion of CSFs 24h after prolactin treatment.
Pooled male and female CSFs for both normal and KC (cells from 6 individual corneas were obtained and the assay was performed on 4 separate cell-wells per individual cornea, for which the values were averaged: n = 6; 4 technical replicates each). The secretion of FGFb in KC CSFs was below the detection limit. Data plotted as individual data points, mean ± SD.
Fig 4
Fig 4. Pooled comparisons for cytokine secretion of CSFs 5h after prolactin treatment.
(a) Mean values of 0ng/ml, 10ng/ml and 1000ng/ml PRL conditions, with pooled values of male and female CSFs, comparing normal and KC CSF cytokine secretion (n = 6). (b) Mean values of 0ng/ml, 10ng/ml and 1000ng/ml PRL conditions, with pooled values of normal and KC CSFs, comparing male and female CSF cytokine secretion (n = 6). Data plotted as individual data points, mean ± SD. (* P ≤ 0.05; ** P ≤ 0.01; *** P ≤ 0.001; **** P ≤ 0.0001). Calculations for reference in S7 Table.
Fig 5
Fig 5. Pooled comparisons for cytokine secretion of CSFs 24h after prolactin treatment.
(a) Mean values of 0ng/ml, 10ng/ml and 1000ng/ml PRL conditions, with pooled values of male and female CSFs, comparing normal and KC CSF cytokine secretion (n = 6). (b) Mean values of 0ng/ml, 10ng/ml and 1000ng/ml PRL conditions, with pooled values of normal and KC CSFs, comparing male and female CSF cytokine secretion (n = 6). Data plotted as individual data points, mean ± SD. (* P ≤ 0.05; ** P ≤ 0.01; *** P ≤ 0.001; **** P ≤ 0.0001). Calculations for reference in S8 Table.

Similar articles

Cited by

References

    1. Khaled ML, Helwa I, Drewry M, Seremwe M, Estes A, Liu Y. Molecular and Histopathological Changes Associated with Keratoconus. BioMed Res Int. 2017;2017: 7803029. 10.1155/2017/7803029 - DOI - PMC - PubMed
    1. Rabinowitz YS. Keratoconus. Surv Ophthalmol. 1998;42: 297–319. 10.1016/s0039-6257(97)00119-7 - DOI - PubMed
    1. Galvis V, Sherwin T, Tello A, Merayo J, Barrera R, Acera A. Keratoconus: an inflammatory disorder? Eye. 2015;29: 843–859. 10.1038/eye.2015.63 - DOI - PMC - PubMed
    1. Hanet M-S, Zimpfer A, Lepper S, Seitz B. Keratoconus-like tomographic changes in a case of recurrent interstitial keratitis. J Ophthalmic Inflamm Infect. 2018;8: 4. 10.1186/s12348-018-0146-7 - DOI - PMC - PubMed
    1. West-Mays JA, Dwivedi DJ. The keratocyte: Corneal stromal cell with variable repair phenotypes. Int J Biochem Cell Biol. 2006;38: 1625. 10.1016/j.biocel.2006.03.010 - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources